Article
Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort.
Annals of the rheumatic diseases - 1 Sept 2010
Salliot Carine, Bombardier Claire, Saraux Alain, Combe Bernard, Dougados Maxime
Abstract excerpt
OBJECTIVE: To assess the effect of reproductive factors, especially hormone replacement therapy (HRT) and its interaction with HLA-DRB1 *01 and/or *04 alleles on the diagnosis of rheumatoid arthritis (RA) and the presence of anti-cyclic citrullinated peptide (CCP) antibodies in women included in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.